The SGLT2 inhibitor empagliflozin (Jardiance) showed some potential for heart failure (HF) prevention in high-risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback